Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage

Journal Article (2023)
Authors

Rita Rosado-Ramos (Universidade Nova de Lisboa, Instituto de Biologia Experimental e Tecnológica)

Gonçalo M. Poças (Universidade Nova de Lisboa)

Daniela Marques (Universidade Nova de Lisboa)

Alexandre Foito (The James Hutton Institute)

David M Sevillano (Student TU Delft)

Mafalda Lopes-da-Silva (Universidade Nova de Lisboa)

Luís G. Gonçalves (Universidade Nova de Lisboa)

Regina Menezes (Instituto de Biologia Experimental e Tecnológica, Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Lisboa, Universidade Nova de Lisboa)

Marcel Ottens (TU Delft - BT/Design and Engineering Education)

G.B. More Authors (External organisation)

Research Group
BT/Design and Engineering Education
Copyright
© 2023 Rita Rosado-Ramos, Gonçalo M. Poças, Daniela Marques, Alexandre Foito, David M Sevillano, Mafalda Lopes-da-Silva, Luís G. Gonçalves, Regina Menezes, M. Ottens, More Authors
To reference this document use:
https://doi.org/10.1038/s41467-023-37561-2
More Info
expand_more
Publication Year
2023
Language
English
Copyright
© 2023 Rita Rosado-Ramos, Gonçalo M. Poças, Daniela Marques, Alexandre Foito, David M Sevillano, Mafalda Lopes-da-Silva, Luís G. Gonçalves, Regina Menezes, M. Ottens, More Authors
Research Group
BT/Design and Engineering Education
Issue number
1
Volume number
14
DOI:
https://doi.org/10.1038/s41467-023-37561-2
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Parkinson's Disease (PD) is a common neurodegenerative disorder affecting millions of people worldwide for which there are only symptomatic therapies. Small molecules able to target key pathological processes in PD have emerged as interesting options for modifying disease progression. We have previously shown that a (poly)phenol-enriched fraction (PEF) of Corema album L. leaf extract modulates central events in PD pathogenesis, namely α-synuclein (αSyn) toxicity, aggregation and clearance. PEF was now subjected to a bio-guided fractionation with the aim of identifying the critical bioactive compound. We identified genipin, an iridoid, which relieves αSyn toxicity and aggregation. Furthermore, genipin promotes metabolic alterations and modulates lipid storage and endocytosis. Importantly, genipin was able to prevent the motor deficits caused by the overexpression of αSyn in a Drosophila melanogaster model of PD. These findings widens the possibility for the exploitation of genipin for PD therapeutics.